Cryoport

$42.09 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Cryoport

Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services, the Company enables its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s subsidiaries include Cryoport Systems, Inc., MVE Biological Solutions, CRYOPDP and Cryogene Partners.

Stock Analysis

last close $39.4
1-mo return 16%
3-mo return 63%
avg daily vol. 341.36T
52-week high 86.3
52-week low 19.82
market cap. $1.9B
forward pe -
annual div. -
roe -46%
ltg forecast -
dividend yield -
annual rev. $222M
inst own. 94.6%
baraka

Subscribe now for daily local and international financial news

Subscribe